After having passed its Factory acceptance tests, the third IBA Cyclone® 70 is leaving the IBA factory and starting its journey towards the final installation site in Moscow
Louvain-la-Neuve, Belgium, January 27th, 2016 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy and radiopharmacy solutions, announces the shipment of its third Cyclone®
70 that will be delivered to the Centre for Development of Nuclear Medicine (CDNM) in Moscow, Russia.
This 70 MeV Cyclotron will be dedicated to the production of new generation medical isotopes used mainly in the diagnosis of severe diseases.
This is in continuation of the achievement of IBA team of experts that have been commissioning the second machine in USA while working on the assembly & tests of the third cyclotron at the same time.
“I’m delighted by the spectacular year of IBA RadioPharma Solutions with the release and installation of the new PET machine, the Cyclone® KIUBE and delivering at the same time two Cyclone® 70 for the development of nuclear medicine and production of important cardiac PET generators.”
said Bruno Scutnaire, President of IBA RadioPharma Solutions.
“Thanks to IBA expertize, our Cyclone® 70 manufacturing and shipment is conducted in the best manner possible,” said Alexander Khasin, CEO of the Centre for Development of Nuclear Medicine. “We are delighted by our collaboration
with IBA and are confident that we will shortly reach our objective to supply the world with medical isotopes for the diagnosis and treatment of critical illnesses.”